Sun, Jul 13, 2014, 5:59 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • josve942 josve942 Sep 18, 2013 2:35 PM Flag

    9/14 DECISION

    SCR200, please answer the question re. fda extending ADCETRIS DURATION.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • We repeatedly tried to tell newbies on this board that the FDA ruling came months ago, that the Adcetris 16-cycle treatment limitation already has been removed, and that the Sept. 14 PDUFA was no longer relevant or even in force. Here is SGEN CEO Clay on this issue just last week: “Clearly, the thing that was most important to us was getting rid of the 16-cycle limitation….,” Siegall said. “We were very pleased to get the 16-cycle cap removed…. We got pretty much everything we were looking for.”

 
SGEN
37.40+1.07(+2.95%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.